CA2030346A1 - Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines - Google Patents

Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines

Info

Publication number
CA2030346A1
CA2030346A1 CA2030346A CA2030346A CA2030346A1 CA 2030346 A1 CA2030346 A1 CA 2030346A1 CA 2030346 A CA2030346 A CA 2030346A CA 2030346 A CA2030346 A CA 2030346A CA 2030346 A1 CA2030346 A1 CA 2030346A1
Authority
CA
Canada
Prior art keywords
treatment
keto
cardiac dysfunction
prostaglandin compounds
prostaglandin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2030346A
Other languages
English (en)
Other versions
CA2030346C (fr
Inventor
Ryuji Ueno
Hiroyoshi Osama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Ueno Seiyaku Oyo Kenkyujo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ueno Seiyaku Oyo Kenkyujo KK filed Critical Ueno Seiyaku Oyo Kenkyujo KK
Publication of CA2030346A1 publication Critical patent/CA2030346A1/fr
Application granted granted Critical
Publication of CA2030346C publication Critical patent/CA2030346C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002030346A 1989-11-22 1990-11-20 Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines Expired - Fee Related CA2030346C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP303840/1989 1989-11-22
JP30384089 1989-11-22

Publications (2)

Publication Number Publication Date
CA2030346A1 true CA2030346A1 (fr) 1991-05-23
CA2030346C CA2030346C (fr) 2000-04-11

Family

ID=17925938

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002030346A Expired - Fee Related CA2030346C (fr) 1989-11-22 1990-11-20 Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines

Country Status (9)

Country Link
EP (1) EP0430551B1 (fr)
JP (1) JPH0791191B2 (fr)
KR (1) KR0167557B1 (fr)
AT (1) ATE162717T1 (fr)
CA (1) CA2030346C (fr)
DE (1) DE69032000T2 (fr)
DK (1) DK0430551T3 (fr)
ES (1) ES2113345T3 (fr)
GR (1) GR3026105T3 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1206997C (zh) * 1997-11-28 2005-06-22 株式会社·R-技术上野 内皮缩血管肽拮抗剂
ES2221859T3 (es) 1999-10-15 2005-01-16 Sucampo Ag Composicion de compuestos biciclicos y procedimiento para su estabilizacion.
US6414016B1 (en) * 2000-09-05 2002-07-02 Sucampo, A.G. Anti-constipation composition
TWI331920B (en) * 2001-11-14 2010-10-21 Sucampo Ag Unit dosage form for relieving or treating constipation in human patients
US7732487B2 (en) 2001-11-19 2010-06-08 Sucampo Ag Method for treating a disease or condition responsive to opening of C1C-2 channel
KR100804525B1 (ko) 2005-03-24 2008-02-20 삼성에스디아이 주식회사 집적회로 칩용 방열부재 및 이를 구비한 디스플레이 모듈
WO2009104205A1 (fr) * 2008-02-20 2009-08-27 Lupin Limited Formulation à libération retardée d’un activateur du canal chlorure
CN102028696B (zh) * 2009-09-24 2013-02-13 上海天伟生物制药有限公司 一种前列腺素类化合物的用途
US10457623B1 (en) 2018-07-13 2019-10-29 Chirogate International Inc. Process for the preparation of Lubiprostone and intermediates thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2328132A1 (de) * 1973-05-30 1975-01-02 Schering Ag Neue prostansaeurederivate und verfahren zu ihrer herstellung
JPS581117B2 (ja) * 1976-01-01 1983-01-10 フアイザ−・インコ−ポレ−テツド １１−デオキシ−ω−ペンタノルプロスタグランジン類
JPS5879973A (ja) * 1981-11-09 1983-05-13 Ono Pharmaceut Co Ltd プロスタグランジン誘導体の重合体、その製造方法及び該重合体を有効成分として含有する治療剤
EP0153858A3 (fr) * 1984-02-29 1985-12-11 The Upjohn Company Application thérapeutique de prostaglandines
JPS60208917A (ja) * 1984-02-29 1985-10-21 ジ・アツプジヨン・カンパニー Ａｒｄｓおよび多器官不全治療、予防におけるプロスタグランジンの使用
JP2597629B2 (ja) * 1988-02-26 1997-04-09 株式会社 上野製薬応用研究所 １３，１４−ジヒドロ−１５−ケトプロスタグランジン類の安定化
JP2597649B2 (ja) * 1988-05-11 1997-04-09 株式会社上野製薬応用研究所 気管・気管支拡張剤
JP2760514B2 (ja) * 1988-07-20 1998-06-04 株式会社 上野製薬応用研究所 循環機能昂進剤
DE68906193T2 (de) * 1988-05-23 1993-08-05 Ueno Seiyaku Oyo Kenkyujo Kk Hypersphyxia verursachende zusammensetzung.

Also Published As

Publication number Publication date
ES2113345T3 (es) 1998-05-01
KR910009270A (ko) 1991-06-28
JPH03218314A (ja) 1991-09-25
JPH0791191B2 (ja) 1995-10-04
DK0430551T3 (da) 1998-04-14
ATE162717T1 (de) 1998-02-15
KR0167557B1 (ko) 1999-01-15
DE69032000D1 (de) 1998-03-05
CA2030346C (fr) 2000-04-11
DE69032000T2 (de) 1998-05-14
EP0430551B1 (fr) 1998-01-28
EP0430551A2 (fr) 1991-06-05
EP0430551A3 (en) 1992-07-15
GR3026105T3 (en) 1998-05-29

Similar Documents

Publication Publication Date Title
AU7404791A (en) Treatment of cataract with 15-keto-prostaglandin compounds
CA2030345A1 (fr) Utilisation d'un compose de 15-ceto-prostaglandines pour l'amelioration des fonctions encephaliques
CA2029596A1 (fr) Medicaments contenant de l'acide lipoique r-a
EP0455448A3 (en) Treatment of pancreatic disease with 15-keto-prostaglandin compounds
ES2093774T3 (es) Estimulacion de la curacion de heridas con un compuesto 15-cetoprostaglandina.
EP0467564A3 (en) Treatment of inflammatory diseases with 15-keto-prostaglandin compounds
CA2030346A1 (fr) Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines
EP0424156A3 (en) Treatment of hepatobiliary disease with 15-keto-prostaglandin compounds
EP0430552A3 (en) Treatment of pulmonary dysfunction with 15-keto-prostaglandin compounds
AU569354B2 (en) (-)-1,7-diphenyl-3-methylaza-7-cyano-8-methylnonane
AU639322B2 (en) Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
EP0469782A3 (en) Treatment of cataract with prostacyclin compounds
AU591419B2 (en) Medicament for curing arteriosclerosis comprising pyrimido (2,1-b) benzothiazole derivative
GR3029726T3 (en) Use of a therapeutic compound for the treatment of bronchitis
AR245225A1 (es) Composiciones para el tratamiento de cuero.
AU4246189A (en) Medicament for the treatment of diseases caused by retroviruses

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed